Radiopharm Theranostics, Ltd

Quick facts

Phase 1 pipeline

• 177Lu-BetaBart · Oncology
  Targeting somatostatin receptors
• 177Lu-RAD202
• 177Lu-RAD204 · Oncology
  Alpha-particle emitting radioligand targeting somatostatin receptors
• LNTH-2403

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Radiopharm Theranostics, Ltd portfolio CI brief
• Radiopharm Theranostics, Ltd pipeline updates RSS